RE: General Meeting7 Apr 2026 12:13
Should see this get going again.
Cash runway to at least H2 2028, pretty long time and no funding worries.
P140 is still in discussions and deal can land at anytime.
Also development of Kapiglucagon for Type 1 diabtetes.
Two big markets, autoimmune disease and diabetes. Mcap is ridiculously low. GLA